## OKLO: Oklo Inc. - XLU: Utilities

### Executive Summary

No thesis match: MRS_20 -9.5% below STRENGTH zone (4.0-10.0%); PEG 1.84 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($64.69)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 1
- **Sentiment:** Bearish (Bullish: 0, Bearish: 0)

**1. Oklo, AppLovin, Teva, Fastly, Intuit: Insider Sell-Offs**
- Source: TipRanks | 20251220T130910 | Somewhat-Bearish | Relevance: 100%
- This article details significant insider stock sell-offs at five companies: Oklo Inc., AppLovin, Teva Pharmaceutical, Fastly, and Intuit. CFO Richard Craig Bealmear sold $5.87 million in Oklo shares, while AppLovin's CALO Victoria Valenzuela sold over $5 million. Teva saw two executives sell a combined $2.7 million, Fastly's President sold $350,347 worth, and Intuit's EVP & CFO Sandeep Aujla offloaded $741,150 in stock. These transactions are highlighted as important data points for investors to consider regarding these companies' outlooks.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-08 | Seaport Global | $150 | $0 | 0% |
| 2025-12-05 | Needham | $135 | $0 | 0% |
| 2025-12-03 | UBS | $95 | $65 | +46% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-08 | Seaport Global | up | Buy |
| 2025-12-05 | Needham | init | Buy |
| 2025-12-03 | UBS | main | Neutral |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 28.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 10 / 0 |

**Top Holders:**
- Vanguard Group Inc: 7.4% (+33.4%)
- Blackrock Inc.: 5.5% (+17.7%)
- Mirae Asset Global E: 4.6% (+71.8%)
- Van Eck Associates C: 2.2% (+61.0%)
- Geode Capital Manage: 1.7% (+17.0%)

### Key Risks

1. Elevated short interest (12.9%): bears positioning against stock.
2. Near-term weakness: 25.7% below SMA50 despite long-term uptrend.
3. Falling knife pattern: rapid decline without stabilization, catch risk elevated.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.84 elevated, pricing in significant growth expectations. Balance sheet: strong liquidity (67.5x), low leverage (D/E 0.03). Analyst sentiment positive (1 raises, avg +46%). Institutional flow bullish (10 buying vs 0 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $13.0B |
| Beta | 0.75 |
| 52W Range | $17.42 - $193.84 |
| Short Interest | 12.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.84 |
| Forward P/E | N/A |
| Current P/E | N/A |
| YoY Growth | N/A |
| EPS Direction | None |

### Technicals

MRS_20 strengthening from -11.4% to -9.5% (+2.0% in 5 days), confirming momentum buildup. Below STRENGTH zone by 13.5pp (needs >4.0% for momentum thesis). MRS_5 turning positive (1.9%) - potential reversal signal. AM_20 at -9.0% indicates price below own 20MA trend. Underperforming sector by 6.6pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.15x) but short-term weakness (below SMA20). MACD histogram bearish (-0.71), momentum weakening. RSI neutral at 41. OFD pattern: -SLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -9.47% (CS: 2) | Weak |
| RSI_14 | 41.0 | Neutral |
| MACD Histogram | -0.71 | Bearish |
| vs SMA20 | 0.910x | Below |
| vs SMA50 | 0.743x | Below |
| vs SMA200 | 1.150x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $83.39
- **Stop Loss:** $64.69 (22.4% risk)
- **Target:** $102.09 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 32
- **Position Value:** $2,668.48
- **Portfolio %:** 2.67%
- **Risk Dollars:** $600.00
- **Risk Per Trade:** 0.60%
- **Modifiers:** L1 120% | L2 50% | Combined 0.60x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-03-23 (Est: $-0.16)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $-0.12 | $-0.20 | -60.9% |
| 2025Q2 | $-0.11 | $-0.18 | -63.6% |
| 2025Q1 | $-0.11 | $-0.07 | +36.4% |
| 2024Q4 | $-0.07 | $-0.09 | -22.7% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*